Does TRICARE Cover Ozempic? Yes for Diabetes, Rarely for Weight Loss

Key Takeaways

• TRICARE covers Ozempic for type 2 diabetes with prior authorization in 2026.
• TRICARE does not cover Ozempic for weight loss. Wegovy (the weight-loss formulation of semaglutide) has limited TRICARE coverage and requires medical-necessity documentation.
• Copays vary by pharmacy type. The TRICARE Pharmacy Home Delivery copay is the lowest; retail network copay is higher.
• TRICARE patients are not eligible for the Novo Nordisk savings card because TRICARE is a federal program.
• Step therapy may apply: TRICARE often requires a trial of metformin or another less expensive medication before approving Ozempic.

Direct answer (40-60 words)

Yes, TRICARE covers Ozempic for type 2 diabetes with prior authorization. Copays in 2026 range from $14 (mail-order generic tier) to $76 (non-formulary retail). TRICARE does not cover Ozempic for weight loss. Wegovy coverage is limited. TRICARE beneficiaries can't use the Novo Nordisk savings card because TRICARE is a federal program.

Table of contents

1. The 30-second answer
2. TRICARE coverage of Ozempic for type 2 diabetes
3. TRICARE coverage of Ozempic for weight loss
4. TRICARE Wegovy coverage in 2026
5. Prior authorization requirements
6. Step therapy: what TRICARE requires before approving Ozempic
7. TRICARE Ozempic copays by pharmacy type
8. Why the manufacturer savings card doesn't work for TRICARE
9. Compounded semaglutide for TRICARE patients without coverage
10. How to verify your specific TRICARE coverage in 5 minutes
11. FAQ
12. Sources

TRICARE coverage of Ozempic for type 2 diabetes

TRICARE includes Ozempic on its formulary for type 2 diabetes management, the FDA-approved indication for the medication. Coverage applies across all major TRICARE plan types:

• TRICARE Prime
• TRICARE Select
• TRICARE For Life (with Medicare as primary)
• TRICARE Reserve Select
• TRICARE Retired Reserve
• TRICARE Young Adult

For all of these plans, Ozempic is generally classified as a non-generic formulary medication, which sets the copay tier. Coverage requires that the prescription be for an approved diabetes use and that prior authorization criteria are met.

The 2024 TRICARE Pharmacy Benefit Manual specifies coverage for GLP-1 receptor agonists (including semaglutide) for type 2 diabetes when at least one prior diabetes medication has been tried (TRICARE Pharmacy Benefit Manual 2024). The same manual restricts coverage for weight-loss indications.

TRICARE coverage of Ozempic for weight loss

TRICARE does not cover Ozempic when prescribed off-label for weight loss. Ozempic is FDA-approved for type 2 diabetes, not for weight management. TRICARE follows the FDA-approved indication strictly for this medication.

If your provider writes "Ozempic for weight loss" or codes the prescription with an obesity diagnosis (E66.x), the TRICARE pharmacy benefit will deny coverage. Patients in this situation typically have three options:

1. Discuss with your provider whether a type 2 diabetes diagnosis applies, in which case Ozempic may be covered.
2. Ask about Wegovy, which is FDA-approved for weight loss and has narrower but real TRICARE coverage.
3. Pay cash or pursue compounded semaglutide outside the TRICARE benefit.

This is a common point of confusion because Ozempic and Wegovy contain the same active ingredient (semaglutide) at different maximum doses. TRICARE treats them as separate products with separate coverage rules.

TRICARE Wegovy coverage in 2026

TRICARE began covering Wegovy in 2023 under specific clinical criteria. As of 2026, coverage typically requires:

• Body mass index (BMI) of 30 or higher, OR
• BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, sleep apnea)
• Documentation of a prior weight-loss attempt with diet, exercise, and behavioral counseling
• Prior authorization submitted by the prescribing provider
• Often, a step-therapy trial of phentermine or another less-expensive weight-loss medication

Coverage criteria can change each year. The Defense Health Agency publishes pharmacy benefit updates periodically (Defense Health Agency 2024).

For active-duty service members, weight management is also tied to fitness standards, which can affect medical necessity documentation. For retirees and dependents, the BMI plus comorbidity model is the most common path to approval.

Prior authorization requirements

TRICARE prior authorization for Ozempic typically requires:

• A type 2 diabetes diagnosis (ICD-10 code E11.x)
• Recent A1c lab value (usually within 90 days)
• Documentation of prior diabetes medication trials (typically metformin)
• Provider's clinical justification for choosing Ozempic over alternatives

The prior authorization is submitted by your provider's office to Express Scripts, which administers the TRICARE Pharmacy Program. Approval typically takes 1 to 5 business days for routine requests and longer for cases requiring additional documentation.

If your prior authorization is denied, you have the right to appeal. The TRICARE appeal process involves a peer-to-peer review where your provider can speak directly with a TRICARE pharmacy reviewer.

A 2024 analysis by Express Scripts reported that GLP-1 prior authorization denial rates for TRICARE patients were lower than for commercial plans, in part because the diabetes-only coverage rule reduces the volume of off-label requests (Express Scripts annual drug trend report 2024).

Step therapy: what TRICARE requires before approving Ozempic

TRICARE often applies step therapy to Ozempic, meaning patients must first try a less expensive medication before Ozempic is approved.

The typical step-therapy sequence for type 2 diabetes:

If you've already tried and failed metformin (because of side effects or inadequate glucose control), the prior authorization for Ozempic is straightforward. If you haven't tried metformin and don't have a documented contraindication, TRICARE will likely require you to start there.

The "fail" criteria are usually:

• A1c remains above target (often 7% or higher) after 3 months at the maximum tolerated dose
• Significant side effects requiring discontinuation
• A documented contraindication (kidney function below a certain threshold for metformin, for example)

TRICARE Ozempic copays by pharmacy type

TRICARE pharmacy copays in 2026 depend on where you fill your prescription. Three options exist:

Source: 2026 TRICARE pharmacy copay schedule (Defense Health Agency 2025).

For Ozempic specifically, the formulary brand copay applies:

• Military pharmacy: $0 if Ozempic is stocked at the facility (rare for non-essential injectables)
• Mail-order: $38 per 90-day supply (one of the better deals in U.S. pharmacy)
• Network retail: $43 per 30-day supply

Mail-order is the lowest-cost option for most TRICARE Ozempic patients. A 90-day mail-order fill at $38 works out to about $12.67 per month, vastly cheaper than commercial cash prices.

Why the manufacturer savings card doesn't work for TRICARE

The Novo Nordisk Ozempic savings card explicitly excludes patients enrolled in any government-funded healthcare program, including:

• Medicare
• Medicaid
• TRICARE
• Veterans Affairs (VA)
• Indian Health Service (IHS)
• Any state pharmaceutical assistance program

This is a federal regulatory rule, not a Novo Nordisk marketing decision. The federal Anti-Kickback Statute prohibits drug manufacturers from offering copay assistance to patients with federal healthcare coverage because doing so could be viewed as inducing prescriptions paid for by federal programs.

The practical implication for TRICARE patients: if your TRICARE Ozempic copay is high (for example, the $76 non-formulary tier), you can't reduce it with the savings card. Your options are mail-order (which is much cheaper than retail), the manufacturer's separate Patient Assistance Program (income-based), or a switch to a covered alternative.

Compounded semaglutide for TRICARE patients without coverage

For TRICARE patients whose Ozempic prescription is denied (most commonly because of a weight-loss indication or because step therapy hasn't been completed), compounded semaglutide is an option used outside the TRICARE benefit.

Compounded semaglutide:

• Is dispensed by state-licensed 503A compounding pharmacies in response to an individual prescription
• Is not FDA-approved
• Is not covered by TRICARE or any other major insurance
• Typically costs $179 to $499 per month at major telehealth platforms
• Is drawn from a vial with a U-100 insulin syringe

For TRICARE patients seeking weight management, compounded semaglutide offers an alternative path when the TRICARE benefit doesn't apply. (See our why compounded semaglutide is red and tirzepatide dosage chart guides for safety and dosing basics.)

The trade-off: compounded medications don't go through the same FDA review as brand-name products and aren't interchangeable with Ozempic or Wegovy.

How to verify your specific TRICARE coverage in 5 minutes

Step 1: Log into milConnect or the TRICARE West/East beneficiary portal. Pull up your pharmacy benefit summary.

Step 2: Search the TRICARE formulary for "semaglutide" or "Ozempic." The formulary search tool returns the medication's tier, prior authorization status, and copay.

Step 3: Call Express Scripts at 1-877-363-1303 (the TRICARE Pharmacy Program contact number). Ask about coverage for your specific situation: indication, prior authorization, step therapy.

Step 4: Talk to your provider's office. Ask the staff to run a "test claim" through Express Scripts before the prescription is filled. This returns the exact copay you'd pay.

Step 5: If denied, request the prior authorization appeal pathway. Your provider can submit additional documentation or request a peer-to-peer review.

This 5-minute verification prevents most TRICARE coverage surprises.

FAQ

Does TRICARE cover Ozempic? Yes, for type 2 diabetes with prior authorization. TRICARE does not cover Ozempic for weight loss. Coverage applies across TRICARE Prime, Select, For Life, Reserve Select, Retired Reserve, and Young Adult plans.

Does TRICARE cover Ozempic for weight loss? No. TRICARE follows the FDA-approved indication and won't cover Ozempic when prescribed for weight management. For weight loss, Wegovy may be covered with separate criteria including BMI thresholds and prior authorization.

Does TRICARE cover Wegovy? Yes, with prior authorization. Coverage typically requires BMI of 30 or higher, or BMI of 27 or higher with a weight-related comorbidity, plus documented prior weight-loss attempts. Specific criteria can vary by year.

What does Ozempic cost on TRICARE? Mail-order copay is $38 for a 90-day supply in 2026. Network retail is $43 for a 30-day supply. Non-network retail is higher. Military pharmacies dispense at $0 when stocked.

Why is my TRICARE Ozempic prior authorization denied? Common reasons: the prescription is coded for weight loss, you haven't completed step therapy with metformin, the documentation doesn't include recent A1c, or the prescribing provider isn't TRICARE-credentialed.

Can TRICARE patients use the Novo Nordisk savings card? No. Federal law prohibits manufacturer copay assistance for patients on federal healthcare programs, including TRICARE. The card is restricted to commercial-insurance patients.

Does TRICARE require step therapy for Ozempic? Usually yes. Most TRICARE plans require a trial of metformin (and sometimes a second oral diabetes medication) before approving a GLP-1 agonist. Documented metformin intolerance or contraindication can substitute for the trial.

Is mail-order cheaper than retail for TRICARE Ozempic? Yes. The TRICARE Pharmacy Home Delivery copay of $38 for a 90-day supply works out to roughly $12.67 per month, much cheaper than the $43 retail copay for a 30-day supply.

Does TRICARE For Life cover Ozempic if I have Medicare? Yes, when used for type 2 diabetes. Medicare Part D is primary, and TRICARE For Life acts as secondary coverage to reduce out-of-pocket costs.

Can I get Ozempic from a military pharmacy? Yes if the facility stocks it. Many military pharmacies don't routinely stock Ozempic because of cost and demand variability. Mail-order is more reliable.

What if I'm an active-duty service member and need Ozempic for diabetes? Coverage applies normally with prior authorization. Your provider may also document fitness implications. Active-duty members can use military pharmacies, mail-order, or network retail.

Is there an income-based assistance program TRICARE patients can use? Yes. The Novo Nordisk Patient Assistance Program (NovoCare PAP) provides Ozempic free to qualifying low-income patients. Eligibility is generally income below 400% of the federal poverty level, with no requirement to be uninsured.

Sources

1. Defense Health Agency. TRICARE Pharmacy Program copayment schedule, fiscal year 2026. 2025.
2. Defense Health Agency. TRICARE Pharmacy Benefit Manual. 2024.
3. Express Scripts. 2024 Drug Trend Report. 2024.
4. Novo Nordisk. Ozempic (semaglutide) prescribing information. 2024.
5. Novo Nordisk. Wegovy (semaglutide) prescribing information. 2023.
6. American Diabetes Association. Standards of Medical Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321.
7. U.S. Department of Health and Human Services Office of Inspector General. Special Advisory Bulletin on Patient Assistance Programs and Federal Health Programs. 2014.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. TRICARE is a registered trademark of the U.S. Department of Defense. Express Scripts is a registered trademark of Express Scripts Holding Company. FormBlends is not affiliated with, endorsed by, or sponsored by any of these organizations.